The British Journal of Psychiatry (2006) 189: 461-463. doi: 10.1192/bjp.bp.105.017335
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data supplement
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by FARROW, T. F. D.
Right arrow Articles by SPENCE, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FARROW, T. F. D.
Right arrow Articles by SPENCE, S. A.

SHORT REPORTS

Modafinil and unconstrained motor activity in schizophrenia

Double-blind crossover placebo-controlled trial

TOM F. D. FARROW, PhD, MICHAEL D. HUNTER, MRCPsych, ROZANA HAQUE, MBChB and SEAN A. SPENCE, MD, FRCPsych

Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, UK

Correspondence: Dr Tom F. D. Farrow, SCANLab, Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK. Email: t.f.farrow{at}sheffield.ac.uk

Declaration of interest This study was funded by a grant awarded to S.A.S. by Cephalon UK, the manufacturers of modafinil. The sponsor was involved in the study design, but had no role in data collection, analysis, the writing of the reportor the decision to submit the paper for publication.

Avolition affects quality of life in chronic schizophrenia. We investigated the effect of modafinil upon unconstrained motor activity in 18 male patients. In a randomised crossover design study, wrist-worn actigraphic monitors were used to objectively record motor activity over a 20 h period. Patients’ total activity was significantly greater when given the drug. These data suggest that modafinil increases quantifiable motor behaviour in schizophrenia and may have an impact on avolition.




This article has been cited by other articles:


Home page
 Schizophr BullHome page
S. Morein-Zamir, D. C. Turner, and B. J. Sahakian
A Review of the Effects of Modafinil on Cognition in Schizophrenia
Schizophr Bull, November 1, 2007; 33(6): 1298 - 1306.
[Abstract] [Full Text] [PDF]